Study on MAFLD-related Cirrhosis Prevention and Treatment Strategies
Status:
Not yet recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
To establish a prospective, multicenter, biopsie-confirmed clinical cohort of MAFLD-related
cirrhosis (F3-F4) in China, and analyze the clinical, histopathological features and natural
outcomes of MAFLD-associated liver fibrosis/cirrhosis in China. And than to conducted a
real-world study of different strategies of Chinese characteristics for the prevention and
treatment of MAFLD-related cirrhosis to evaluate the efficacy and safety of the strategies.
Phase:
N/A
Details
Lead Sponsor:
The Affiliated Hospital of Hangzhou Normal University